BCG (Bacillus Calmette-Guérin) intravesical solution
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BCG (Bacillus Calmette-Guérin) intravesical solution, covering 2022-10-20 to 2022-10-20. Get the full timeline:
Most recent: Clinical Trial Update: Pembrolizumab and BCG Solution in Treating Patients With Recurrent Non-Muscle-Invasive Bladder Cancer [Phase 1]